Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000808824 | SCV000948946 | uncertain significance | Familial hemophagocytic lymphohistiocytosis 3 | 2021-08-31 | criteria provided, single submitter | clinical testing | |
New York Genome Center | RCV000808824 | SCV002097666 | uncertain significance | Familial hemophagocytic lymphohistiocytosis 3 | 2020-07-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002537299 | SCV003683432 | uncertain significance | Inborn genetic diseases | 2021-11-12 | criteria provided, single submitter | clinical testing | The c.1532A>C (p.K511T) alteration is located in exon 17 (coding exon 17) of the UNC13D gene. This alteration results from a A to C substitution at nucleotide position 1532, causing the lysine (K) at amino acid position 511 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |